Solid dividend-paying stocks make sense for the rest of this year. While it looks like the stress from the Brexit vote is over for the time being, other factors like the political…
The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a great opportunity…
July 1, 2016: Markets opened higher down slightly Friday before climbing to mid-morning highs only to trail lower for much of the day, before heading higher about an hour before the closing…
The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.…
Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to a whopping $161.4 billion.
June 21, 2016: Markets opened higher again Tuesday ahead of Fed chairwoman Janet Yellen’s appearance on Capitol Hill. The odds continue to improve that British voters will not choose to leave the…
The top analyst upgrades, downgrades and initiations seen on Monday morning include Chesapeake Energy, Motorola Solutions, Pfizer, Spirit Air, Symantec, Under Armour and US Foods.
June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be far less…
June 15, 2016: Markets opened higher Wednesday on hopes that the the FOMC meeting would leave interest rates unchanged, the outcome most people expected and the actual outcome as it turned out.…
Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.
Chris Lange The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
June 8, 2016: Markets opened higher for a third straight day Wednesday boosted by rising crude oil prices and a falling dollar. An premarket jump in shares of LendingClub helped out until…
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it…
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
